ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,469.30
      0.39%
      US Tech 100
      19,175.20
      0.00%
      Dow Jones
      39,112.16
      -0.76%
      Brent Oil
      84.405
      0.26%
      Bitcoin
      61,564.50
      -0.40%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aileron Therapeutics Inc (ALRN)

      7. Aileron Therapeutics Inc (ALRN) Financials

      Aileron Therapeutics Inc

      Aileron Therapeutics Inc (ALRN)

      NASDAQ
      3.00
      0.00
      (0.00%)
      Closed June 26 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Aileron Therapeutics Inc Financial Summary

      The current ALRN market cap is 64.77M. The company's latest EPS is USD -0.7287 and P/E is -4.08.

      Income Statement

      Annual Quarterly
      Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -4.7M-5.01M-1.99M-1.98M-7.29M
      Net Income -4.55M-4.78M-1.79M-1.83M-7.34M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -29.96M-20.5M-26.61M-27.65M-16.28M
      Net Income -29.37M-21.16M-26.16M-27.33M-15.73M

      Balance Sheet

      Annual Quarterly
      Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 22.01M17.16M13.99M12.82M106.01M
      Total Liabilities 3.38M2.88M1.2M1.62M7.71M
      Total Equity 18.62M14.27M12.79M11.2M98.3M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 26.47M16.34M48.48M22.01M106.01M
      Total Liabilities 10.43M4.18M4.58M3.38M7.71M
      Total Equity 16.05M12.16M43.9M18.62M98.3M

      Cash Flow

      Annual Quarterly
      Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -24.87M-4.66M-7.78M-9.42M-19.81M
      Investing 26.46M7.25M15.75M16.29M16.2M
      Financing N/A N/A N/A N/A 15.79M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -26.47M-20.48M-23.75M-24.87M-19.81M
      Investing -2.81M6.41M-35.92M26.46M16.2M
      Financing 23.96M15.8M55.66M N/A 15.79M

      Stats and Ratios

      Market Cap 64.77M
      Price to Earnings Ratio -4.08
      Price to Sales Ratio 0
      Price to Cash Ratio 3.7
      Price to Book Ratio 0.65
      Dividend Yield -

      Share Statistics

      Shares Outstanding 21.59M
      Average Volume (1 week) 244.52k
      Average Volume (1 Month) 88.1k
      52 Week Change 71.43%
      52 Week High 7.42
      52 Week Low 1.01
      Spread (Intraday) 0.45 (13.76%)

      Company Info

      Company Name Aileron Therapeutics Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.aileronrx.com
      Industry pharmaceutical preparations (2834)